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Abstract
Background: Acute otitis media with perforation (AOMwiP) affects 40% of remote Indigenous children during the
first 18 months of life. Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis are the primary
bacterial pathogens of otitis media and their loads predict clinical ear state. Our hypothesis is that antecedent
respiratory viral infection increases bacterial density and progression to perforation.
Methods: A total of 366 nasopharyngeal swabs from 114 Indigenous children were retrospectively examined.
A panel of 17 respiratory viruses was screened by PCR, and densities of S. pneumoniae, H. influenzae and
M. catarrhalis were estimated by quantitative real time PCR. Data are reported by clinical ear state.
Results: M. catarrhalis (96%), H. influenzae (91%), S. pneumoniae (89%) and respiratory viruses (59%) were common;
including rhinovirus (HRV) (38%), polyomavirus (HPyV) (14%), adenovirus (HAdV) (13%), bocavirus (HBoV) (8%) and
coronavirus (HCoV) (4%). Geometric mean bacterial loads were significantly higher in children with acute otitis
media (AOM) compared to children without evidence of otitis media. Children infected with HAdV were 3 times
more likely (p < 0.001) to have AOM with or without perforation.
Conclusion: This study confirms a positive association between nasopharyngeal bacterial load and clinical ear state,
exacerbated by respiratory viruses, in Indigenous children. HAdV was independently associated with acute ear states.
Background
Australian Aboriginal children have the highest published
prevalence of acute otitis media (AOM), with and with-
out perforation, in the world [1]. Infants are colonized
with multiple species of respiratory bacteria within weeks
of birth, including the AOM pathogens, S. pneumoniae,
H. influenzae and M. catarrhalis. Early dense coloniza-
tion predicts early onset of otitis media, and progression
to tympanic membrane perforation (TMP) occurs in 30%
of children by 6 months of age and 40% by 18 months of
age [2,3]. At any one time few as 8% of remote Indigen-
ous children aged 6 - 30 months have bilaterally normal
middle ears [1].
Understanding the burden of otitis media (OM) in
remote indigenous populations is complex. Overcrowd-
ing [4], poor hygiene [5], limited formal education [6],
and inadequate access to under-resourced medical
services contribute to the prevalence and severity of
OM in these children [2,3]. Recurrent OM and perfora-
tion is associated with conductive hearing loss and
further contributes to poor educational outcomes [7].
To date, interventions for otitis media have had mod-
est benefits for Indigenous children in remote commu-
nities [8]. A randomised controlled trial in the Northern
Territory, comparing antibiotics for the treatment of
AOM, showed no difference in the risk of clinical failure
between amoxicillin (54% failure rate) and azithromycin
(50% failure rate) treatment groups despite significant
reductions in carriage density of S. pneumoniae and
H. influenzae in the azithromycin group [9].
The introduction of the seven-valent pneumococcal
vaccine (7vPCV) in 2001 brought anticipation of a
reduced OM burden. However a review of randomised
controlled trials using PCVs to prevent AOM in children
aged 12 years or younger, sourced from the Cochrane
Central Register of Controlled Trials, found that the vac-
cine administered during infancy induced only a marginal
reduction in OM disease (6-7%) [10]. In Australia a birth
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cohort study of Indigenous infants found a limited bene-
fit of 7vPCV on OM compared to historic controls. No
effect was observed on the proportion of children with
otitis media with effusion (OME), AOM or AOMwiP at
12 months of age, however, significantly fewer vaccinees
(14%) than controls (23%) experienced chronic suppura-
tive otitis media (CSOM) and vaccinees experienced
delayed onset of TMP [11].
A plausible explanation for the poor response to anti-
biotics and high prevalence of AOM with perforation in
the Indigenous community setting is co-infection of mul-
tiple bacterial pathogens with respiratory viruses. Human
rhinovirus (HRV), respiratory syncytial virus (RSV), influ-
enza virus A and B (FLUA, FLUB), HAdV, HCoV and
parainfluenza virus 1, 2 and 3 (PIV 1, PIV2 & PIV3) are
commonly associated with OM [12-14]. Recent advances
in molecular viral diagnostics [15] now allow a broader
insight into viral OM pathogenesis.
Infection with respiratory viruses induces damage to the
epithelial mucosa of airways, Eustachian tube and middle
ear exposing surface elements that bacteria can adhere to
[16]. The interaction between FLUA and S. pneumoniae is
well noted [17,18]. Influenza neuraminidase is demon-
strated to increase pneumococcal adhesion and invasion
in the Eustachian tube and middle ear [19,20]. RSV can
also facilitate bacterial adhesion. Studies reveal that in the
presence of RSV, certain strains of M. catarrhalis have an
enhanced ability to adhere to epithelial cells [21]. Addi-
tionally, viral mediated inflammation congests the Eusta-
chian tube and further reduces cilial function, inhibiting
bacterial clearance [22,23], while viral immunosuppression
can lead to bacterial superinfection [24]. Recent evidence
suggests that pneumococcal load is driven by FLUA, HRV
and RSV infection, and that enhanced transmission and
acquisition occurs in the presence of FLUA [18,25].
For young Indigenous children, the role of respiratory
viruses in OM remains unclear. In the tropical North of
Australia, AOM is endemic in remote communities and
not subject to seasonal viral outbreaks. In this study we
use molecular methods [3,15] to investigate whether
antecedent nasopharyngeal viral infection increases bac-
terial load and progression to AOMwiP.
Methods
Population and primary data
Samples were sourced from two previous studies based
in the same remote Aboriginal communities. The first,
the COMIT1 trial (1996-2001), was a birth cohort ran-
domized controlled trial that examined the effect of
long course amoxicillin versus placebo on resolution of
first detected OME and the prevention of tympanic
membrane perforation [8]. The second, the PRIORiTI
(PRevenar Immunisation for Otitis media Reductions in
Tiwi Infants) study (2001-2004), was a birth cohort
observational study following the introduction of routine
childhood heptavalent conjugate pneumococcal vaccina-
tion (7vPCV) [11]. In both studies examinations were
undertaken at approximately one month intervals from
birth till 24 months.
Sample collection and clinical definitions have been
described previously [8,11]. In summary, ear state was
defined as follows: (a) Normal: normal or minor pathol-
ogy (abnormal appearance or retracted drum), (b) OME:
either a normal tympanic membrane (TM) or intact,
non-bulging TM, plus type B tympanogram, (c) AOM:
bulging TM, without perforation, and type B tympano-
gram, (d) AOMwiP: middle ear discharge present for less
than 6 weeks and perforation covering less than 2% of
the pars tensa of the TM. (e) CSOM: middle ear dis-
charge present for longer than 6 weeks and perforation
covering greater than 2% of the pars tensa of the TM.
The final middle ear diagnosis reflects the child’s most
severely affected ear. As the focus of this study was acute
ear pathology, swabs from children with CSOM were
excluded.
Analysis of bacterial and viral pathogens was performed
as part of a larger case-control/crossover study (Cheng et
al, manuscript in preparation). Bacterial and viral DNA
was extracted by defined methods [3,15,26,27] and quanti-
tative real time polymerase chain reaction (RTQ-PCR) was
used to determine total and species specific pathogen
loads[3]. The PCR target genes were: 16S rRNA for total
bacterial load [28], autolysin (lytA) for S. pneumoniae load
[29], protein D (hpd) for H. influenzae load [3], and the
outer membrane protein (copB) for M. catarrhalis load
[30]. Specimens were tested for FLUA and B, RSV, PIV 1,
2 and 3, HAdV, human meta-pneumovirus (HMPV),
HRV, enterovirus (EV), HCoV’s (HKU1, OC43, 229E and
NL63), HBoV and HPyV’s (WU and KI) by PCR as pre-
viously described [15,26,27].
Ethics
Informed written consent was obtained from the parents
of all children who participated in the parent studies,
COMIT and PRIORiTI. This work was performed fol-
lowing consultation with Indigenous community mem-
bers, and was approved by the Human Research Ethics
Committee of the Menzies School of Health Research
and the Department of Human Services (HREC - 07/78).
Statistical Analysis
Chi-square or Fischer’s exact analysis was used to com-
pare the proportions of virus and bacteria positive swabs
in each of the four ear states. Bacterial loads were log
normally distributed and therefore were log transformed
for analysis. Non-parametric tests for continuous vari-
ables, Kruskal-Wallis equality of populations rank test
and Mann Whitney Wilcoxon ranksum tests, were used
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to compare bacterial loads between ear states, with or
without viral co-detection. Linear regression was used to
examine the relationships between the bacterial loads
and interacting variables such as age and antibiotic use
(<2 weeks before swab was taken) with lower limits set
at lowest positive load value. The reported p values are
two-tailed and significance was set at 5%. All statistical
analysis was performed using STATA IC version 11
(StataCorp, Texas, USA).
Results
Bacterial and viral infection of the nasopharynx in
relation to ear state
Of the 366 swabs from 114 children, 58 (16%) swabs
were from children diagnosed with tympanic membrane
perforation. 115 (31%) had AOM without perforation,
175 (48%) had OME, and 18 (5%) were from children
with Normal ears (Table 1).
By RTQ-PCR most swabs were positive for M. catarrha-
lis (96%), H. influenzae (91%) and S. pneumoniae (89%).
Greater than 80% had all three and all had at least one of
these pathogens. Although the proportion of positive
swabs was high for all ear states, more children from the
AOM group were positive for each of the bacteria com-
pared to the Normal group (Table 1).
Sixty two percent (228/366) of swabs amplified at least
one virus. A total of 312 viruses were detected in the
228 positive swabs at an average of 1.37 viruses per
positive swab. HRV (38%) was the most frequently
encountered virus, followed by HPyV (14%), HAdV
(13%), HBoV (8%) and HCoV (4%). Other viruses
(FLUA and B, PIV 1,2 and 3, HMPV, RSV and EV)
were only found in <9% collectively (Table 1). Further
investigation of the HPyV subtypes, WU and KI,
revealed the WU virus predominated (92% of HPyV
positive swabs).
The proportions of HAdV detected in the nasopharyn-
geal swabs for each ear diagnosis were: 6% for Normal,
7% for OME, 19% for AOM and 22% for AOMwiP
(Table 1) (Figure 1). No other virus revealed a positive
relationship with ear state.
Bacterial load in the nasopharynx in relation to ear state
The geometric-mean bacterial loads were high through-
out. Individual bacterial loads showed stepwise elevations
by categorical ear state for M. catarrhalis, H. influenzae
and S. pneumoniae, peaking at AOM (Figure 2). Unex-
pectedly, the individual bacterial loads were lower at the
time of AOM with perforation than at AOM without
perforation. A dichotomous ranksum test revealed a sig-
nificantly higher load in the AOM group compared
to Normal group for M. catarrhalis (N = 5.42 × 104,
AOM = 2.19 × 106; p = 0.005); H. influenzae (N = 1.33 ×
105, AOM = 1.09 × 106; p = 0.031); and S. pneumoniae
(N = 2.44 × 103, AOM = 2.68 × 105; p = 0.004). The total
bacterial loads were all greater than 107, showing no
trend for ear state.
Bacterial load in the nasopharynx when viruses were
present
In the presence of viruses the individual loads had a
general trend upwards (Figure 3). The combined load of
M. catarrhalis, H. influenzae and S. pneumoniae was
greater when examined by presence or absence of any
Table 1 Data description by clinical ear state
Variable Total Normal OME AOM AOMwiP P
Number of kids 114 - - - - na
Number of swabs (% of total) 366 18(5) 175(48) 115(31) 58(16) na
Mean age months (median) 8.0 5.4 (3.4) 7.2 (6.6) 8. (7.7) 8.5 (8.1) <0.001 *
Bacteria detection (% of total)
Any bacteria 366(100) 18(100) 175(100) 115(100) 58(100) na **
Spn 327(89) 11(61) 155(89) 109(95) 52(90) <0.001 **
Hinf 333(91) 16(89) 155(89) 110(96) 52(90) 0.211 **
Mcat 351(96) 14(78) 167(95) 113(98) 57(98) <0.001 **
Virus detection (% of total)
Any virus 228(62) 12(67) 102(58) 78(68) 36(62) 0.416 **
Total virus (virus:swab(+)ratio) 312(1.37) 14(1.17) 134(1.31) 117(1.51) 47(1.31) 0.120 **
HBoV 28(8) 0(0) 14(8) 10(9) 4(7) 0.627 **
HPyV 50(14) 6(33) 20(11) 19(17) 5(9) 0.034 **
HAdV 49(13) 1(6) 13(7) 22(19) 13(22) 0.003 **
HRV 139(38) 5(28) 69(39) 47(41) 18(31) 0.467 **
HCoV 14(4) 0(0) 7(4) 5(4) 2(3) 0.840 **
Other 32(9) 2(11) 11(6) 14(12) 5(9) 0.369 **
P shows the significance of the values across all ear states using either the: (*) Kruskal-Wallis equality-of-populations rank test, or the (**) Chi-square test.
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study virus (p = 0.035) (data not shown). Of the indivi-
dual bacterial pathogens, significantly higher loads were
only seen for H. influenzae co-infected with any study
virus (Virus +), HPyV and HCoV (Table 2) (Figure 3).
Despite the association between HAdV and ear disease,
load increases in the presence of adenovirus were
insignificant.
Association between bacterial load and other known
factors
The impact of sex, age, antibiotic use and number of
viruses detected were assessed using linear regression
(Table 2). The loads of M. catarrhalis, H. influenzae and
S. pneumoniae were significantly lower in children less
than 3 months of age. This was in part due to the
greater proportion of children without detectable OM
bacteria at this early age. In children older than 3
months the effect of age on load was neutral. Linear
regression also revealed that the density of M. catarrha-
lis and H. influenzae was positively influenced by
respiratory viral infection while the impact of sex and
antibiotic use (<2 weeks before swab was taken) on load
was negligible. Furthermore, comparison of total and
pathogen specific loads with and without antibiotics, for
each ear state, did not reveal any significant differences
(data not included).
Correlation between molecular bacterial load and semi-
quantitative microbiology
The positive correlation between the bacterial loads
determined by RTQ-PCR and clinical ear state was con-
sistent with original semi-quantitative microbiology
(data not included). Sensitivity was enhanced using
RTQ-PCR. Of the 356 swabs cultured for M. catarrhalis,
82% were culture positive and 96% were RTQ-PCR posi-
tive. Similarly for H. influenzae; 75% were culture posi-
tive and 91% were RTQ-PCR positive. All 366 swabs
were cultured for S. pneumoniae of which 68% were cul-
ture positive and 89% were RTQ-PCR positive. 14%,
20% and 23% of swabs were culture negative and RTQ-
PCR positive for M. catarrhalis, H. influenzae and S.
pneumoniae respectively. 1%, 5% and 2% of swabs were
culture positive but RTQ-PCR negative respectively.
Limitations of the study
The bacterial load estimates have limitations: The quan-
tity of material obtained on the swab was assumed to be
equal for all swabs; DNA extraction efficiency was con-
sidered to be 100%; and molecular weight calculations
were based on estimates of GC content. Additionally
when quantifying the total bacterial load using 16S pri-
mers, we used S. pneumoniae with 4 ribosomal operons
Figure 1 Proportion of HAdV positive nasopharyngeal swabs by
clinical ear state. A significantly greater number of swabs were HAdV
positive in children with acute OM with and without perforation.
Figure 2 Bacterial load versus Clinical Ear State. The geometric mean bacterial loads are segregated by clinical ear state for each bacterial
pathogen. A significantly higher load was seen for M. catarrhalis, H. influenzae and S. pneumoniae in children with AOM compared to Normal ear
states (Mann Whitney Wilcoxon test). Significant differences in the loads across the ear states, for M. catarrhalis and S. pneumoniae, were
confirmed by the Kruskal-Wallis equality of populations rank test. There was no significant difference in geometric mean of the Total Bacterial
Load between ear states.
Binks et al. BMC Infectious Diseases 2011, 11:161
http://www.biomedcentral.com/1471-2334/11/161
Page 4 of 8
as our control. The actual number of ribosomal operons
varies greatly between species. Importantly, load values
remain relative to each other throughout. It is worth
noting that the hpd (protein D) target is likely to be pre-
sent in closely related Haemophilus species including
non-haemolytic H. haemolyticus and as such this study
may over represent classical non-typeable H. influenzae.
Our swabs were collected at monthly intervals, so we
have assumed that microbiology at the time of diagnosis
best approximates the aetiology of that event. However
our definition of the primary perforation included per-
foration of less than 6 weeks duration. The exact date of
onset was not available. This analysis describes the nasal
microbiology and ear status at the time of swab collec-
tion and presents the data for Normal, OME, AOM and
AOMwiP. Furthermore, while the nasopharynx and the
middle ear show concordance of infection, studies sug-
gest a lapse of 3-10 days between upper respiratory
symptoms and onset of otitis media [31,32]. It is there-
fore plausible that bacterial load and viral detection will
be greater in swabs collected prior to perforation, com-
pared to swabs collected at or after the time of
perforation.
Discussion
In this study the high bacterial carriage rates, high bac-
terial loads, and small number of children with Normal
ears (5% of swabs), reflect the large burden of respira-
tory infection in Indigenous children who live in remote
communities. Increases in individual respiratory bacter-
ial load (and carriage) were apparent with worsening ear
state with a peak at AOM, whereas the total bacterial
load was high regardless of ear state.
The broad viral panel scrutinized by sensitive PCR
methods in this study revealed a high proportion of
virus positive nasopharyngeal swabs (62% swabs or 89%
children). The proportions remained stable by ear state
including the Normal group, of which 67% were positive
for any study virus. HRVs, which are responsible for
more cold-like illnesses than any other virus [33], were
the most prevalent viruses identified in this study (38%),
though no clear correlation between HRV and clinical
ear state was observed.
HAdV was significantly associated with acute ear
pathology (Figure 1). Children with AOM or AOMwiP
were infected with HAdV at 3 times the rate of children
with Normal and OME diagnosis (P < 0.001) though
this was not associated with a significant increase in
bacterial load. HAdV is increasingly reported as an
upper respiratory pathogen with studies showing occur-
rence of AOM in up to 50% of those children infected
[12-14,34]. No licensed HAdV treatment is currently
available [35].
Overall our data supports a potential role for viruses
in AOM, particularly HAdV, encouraging prospective
studies and clinical trials to better understand the role
viruses might have in endemic OM.
Differences in bacterial load with viral co-infection
were apparent but of limited significance. H. influenzae
load was significantly elevated in the presence of HPyV,
HCoV and any study virus, and linear regression revealed
that the loads of M.catarrhalis and H. influenzae were
higher with detection of multiple viruses (Figure 3)
(Table 2). At no point were the individual bacterial loads
lower in the presence of a virus. We suspect that the con-
sistently high bacterial loads seen in these children might
mask the true effect of respiratory viruses on bacterial
density.
The higher individual loads seen in AOM swabs com-
pared to AOMwiP swabs were unexpected. We suggest
that this is likely due to the mismatch in timing of onset
and swab collection.
Regression modelling of bacterial load by age revealed
significantly lower loads for all three individual bacterial
Figure 3 Bacterial Loads in the presence of common respiratory viruses. Significantly higher load was found for H. influenzae in the
presence of any study virus, HPyV and HCoV, compared to no viral co-infection. The dotted line represents the baseline mean load in the
absence of viral co-infection.
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Table 2 Univariate linear regression analysis of bacterial load by known variables
Variables N Geometric Mean Bacterial Load (SD) Coefficient (95% CI) P
M. catarrhalis Sex Male 180 14.26(2.89) -0.29(-0.82 to 0.24) 0.279
Female 186 13.77(3.89)
Age category <3mo 36 11.59(5.96) -2.31(-3.44 to -1.18) <0.001
3-6mo 95 14.41(2.92) -0.45(-1.37 to 0.47) 0.336
6-9mo 122 13.85(3.51) -0.88(-1.77 to 0.00) 0.051
9-12mo 71 14.50(1.77) -0.47(-1.44 to -0.49) 0.335
>12mo 42 14.84(2.68) Baselevel –
Overall 0.001
Antibiotics No 193 13.78(3.57) 0.42(-0.11 to 0.95) 0.123
(<2 weeks) Yes 173 14.27(3.29)
Number of viruses 0 138 13.51(4.09) Baselevel –
1 153 14.08(3.42) 0.42(-0.17 to 1.01) 0.166
>1 75 14.79(1.56) 0.92(0.20 to 1.64) 0.013
Overall 0.042
H. influenzae Sex Male 180 12.96(4.61) 0.21(-0.38 to 0.80) 0.478
Female 186 13.24(4.48)
Age category <3mo 36 10.26(7.10) -1.71(-3.0 to -0.43) 0.009
3-6mo 95 13.46(4.50) -0.01(-1.04 to 1.01) 0.981
6-9mo 122 13.23(4.29) -0.33(-1.32 to 0.66) 0.513
9-12mo 71 13.36(3.71) -0.32(-1.39 to 0.76) 0.565
>12mo 42 13.91(2.80) Baselevel –
Overall 0.041
Antibiotics Yes 193 12.82(4.96) 0.22(-0.36 to 0.81) 0.455
(<2 weeks) No 173 13.41(4.00)
Number of viruses 0 138 12.35(5.13) Baselevel –
1 153 13.34(4.35) 0.65(-0.01 to 1.30) 0.05
>1 75 13.98(3.46) 1.00(0.21 to 1.81) 0.013
Overall 0.029
S. pneumoniae Sex Male 180 12.22(3.96) -0.41(-0.93 to 0.11) 0.119
Female 186 11.39(4.80)
Age category <3mo 36 9.83(6.03) -1.13(-2.26 to -0.02) 0.05
3-6mo 95 12.61(3.40) 0.22(-0.68 to 1.13) 0.627
6-9mo 122 11.54(4.92) -0.20(-1.08 to 0.67) 0.647
9-12mo 71 11.89(3.84) -0.37(-1.32 to 0.58) 0.448
>12mo 42 12.25(3.82) Baselevel –
Overall 0.083
Antibiotics Yes 193 11.84(4.25) 0.05(-0.47 to 0.56) 0.862
(<2 weeks) No 173 11.76(4.62)
Number of viruses 0 138 11.30(4.96) Baselevel –
1 153 12.13(3.99) 0.34(-0.24 to 0.92) 0.252
>1 75 12.04(4.19) 0.73(-0.35 to 1.07) 0.319
Overall 0.444
Total Bacterial Load Sex Male 180 17.46(1.65) -0.06(-0.40 to 0.28) 0.74
Female 186 17.40(1.65)
Age category <3mo 36 17.52(2.12) 0.27(-0.46 to 1.00) 0.464
3-6mo 95 17.71(1.44) 0.46(-0.14 to 1.06) 0.131
6-9mo 122 17.45(1.76) 0.21(-0.37 to 0.79) 0.48
9-12mo 71 17.10(1.50) -0.15(-0.78 to 0.48) 0.646
>12mo 42 17.25(1.46) Baselevel –
Overall 0.185
Antibiotics Yes 193 17.36(1.61) 0.14(-0.20 to 0.48) 0.414
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pathogens in children less than 3 months of age. In chil-
dren older than 3 months, age exerted no influence on
load. This finding reflects the natural acquisition of
these bacteria after birth. No differences in the bacterial
loads were observed between the sexes or with antibiotic
use in the fortnight prior to examination and swabbing
(Table 2). Treatment guidelines recommend antibiotic
use upon diagnosis of AOM. The effect of antibiotic use
on loads, by ear state, was also investigated (data not
included). No differences in the bacterial loads were
observed, with or without antibiotic use, in swabs taken
at a diagnosis of AOM or AOMwiP.
Viral-bacterial co-infections are often associated with
antibiotic treatment failure [36]. In the Indigenous chil-
dren in our study, antibiotic therapy had no discernable
effect on bacterial loads. For densely colonised children
with treatment failure, more work is needed to deter-
mine whether antiviral medication might be a valid
adjunct to antibiotic treatment. Recently a randomized
controlled trial in the United States found that children
receiving oseltamivir (Tamiflu) treatment within 48
hours of clinic presentation for laboratory confirmed
influenza were considerably less likely to progress to
AOM. This effect was greatest for children between the
ages 1-5 years old where the incidence of AOM was the
greatest [37].
The limited clinical impact of PCV7 on OM in indi-
genous children is largely attributed to pneumococcal
serotype replacement. This study however, suggests that
the influence of respiratory viruses on OM in this popu-
lation may be undervalued. A review by Cripps and Otc-
zyk in 2006 promotes a vaccine that includes both
bacterial and viral antigens [38] and others have shown
that the influenza vaccine can reduce overall AOM inci-
dence by greater than 30% [39-41]. Whether vaccines
for individual viruses would have an impact on endemic
OM is unclear, but protection against multiple patho-
gens may be needed to attenuate the complex interplay
between viruses and bacteria in OM in high risk
populations.
Conclusions
For Indigenous children with OM this study highlights
the frequency of viral infection, describes increasing bac-
terial density with progression to AOM, suggests a
synergy of viral-bacterial co-infection, and implicates
adenovirus in AOMwiP pathogenesis. Antibiotic and
antiviral therapy is ever expanding and improving and it
seems likely that only vaccines and/or chemotherapies
targeting multiple bacterial and viral species, in combi-
nation with successful social interventions to reduce
cross infection, will reduce OM prevalence, morbidity
and sequelae in high risk populations. The introduction
of the 10-valent pneumococcal conjugate vaccine, with
broader pneumococcal serotype coverage and potential
protection from the addition of the H. influenzae pro-
tein D antigen is possibly the first step in the right
direction.
Acknowledgements
We thank the families and children that participated in this study, the
Northern Territory Department of Health and Community Services, the Tiwi
Health Board, and staff at the clinics involved. Without this support the
study would not have been possible.
Funding
This study was supported by the NHMRC (project grant reference number
490317).
Author details
1Ear and Respiratory Unit, Child Health Division, Menzies School of Health
Research, Charles Darwin University, Darwin 0810, Australia. 2Department of
Epidemiology and Preventive Medicine, Faculty of Medicine, Monash
University, Melbourne 3800, Australia. 3Queensland Paediatric Infectious
Diseases Laboratory, Sir Albert Sakzewski Virus Research Centre, Royal
Children’s Hospital, Brisbane 4029, Australia.
Authors’ contributions
MB performed the DNA extractions, bacterial loads PCR’s, data analysis and
interpretation of results. MB is the author of this work. AC contributed to the
design of the larger case control study from which these samples were
drawn, and assisted with statistical analysis and editing. HSV provided
expertise both to the design of the RTQ-PCR and the writing of this paper.
TS’s laboratory screened the swabs for the 17 respiratory viruses and TS
assisted with interpretation of the virus PCR results. MN provided clinical
interpretation of the virology. DW performed the DNA extractions and PCR
assays to identify the viruses. JM assisted with and proofed the statistical
calculations. AJL concepted this study and contributed significantly to the
analysis and editing of this manuscript. All authors have read and approved
the final version.
Competing interests
The authors declare that they have no competing interests.
Received: 3 February 2011 Accepted: 7 June 2011
Published: 7 June 2011
References
1. Morris PS, Leach AJ, Silberberg P, Mellon G, Wilson C, Hamilton E,
Beissbarth J: Otitis media in young Aboriginal children from remote
Table 2 Univariate linear regression analysis of bacterial load by known variables (Continued)
(<2 weeks) No 173 17.51(1.69)
Number of viruses 0 138 17.42(1.68) Baselevel –
1 153 17.42(1.70) 0.01(-0.37 to 0.39) 0.976
>1 75 17.46(1.48) 0.03(-0.44 to 0.49) 0.901
Overall 0.992
Antibiotic use included any systemic antimicrobial prescription for respiratory infection in the 2 weeks prior to examination and swabbing.
Binks et al. BMC Infectious Diseases 2011, 11:161
http://www.biomedcentral.com/1471-2334/11/161
Page 7 of 8
communities in Northern and Central Australia: a cross-sectional survey.
BMC Pediatr 2005, 5:27.
2. Leach AJ, Boswell JB, Asche V, Nienhuys TG, Mathews JD: Bacterial
colonization of the nasopharynx predicts very early onset and
persistence of otitis media in Australian aboriginal infants. Pediatr Infect
Dis J 1994, 13(11):983-989.
3. Smith-Vaughan H, Byun R, Nadkarni M, Jacques NA, Hunter N, Halpin S,
Morris PS, Leach AJ: Measuring nasal bacterial load and its association
with otitis media. BMC ear nose and throat disorders 2006, 6:10.
4. Lehmann D, Arumugaswamy A, Elsbury D, Finucane J, Stokes A, Monck R,
Jeffries-Stokes C, McAullay D, Coates H, Stanley FJ: The Kalgoorlie Otitis
Media Research Project: rationale, methods, population characteristics
and ethical considerations. Paediatr Perinat Epidemiol 2008, 22(1):60-71.
5. Stubbs E, Hare K, Wilson C, Morris P, Leach AJ: Streptococcus pneumoniae
and noncapsular Haemophilus influenzae nasal carriage and hand
contamination in children: a comparison of two populations at risk of
otitis media. Pediatr Infect Dis J 2005, 24(5):423-428.
6. Johnston V, Lea T, Carapetis J: Joining the dots: The links between
education and health and implications for indigenous children. J
Paediatr Child Health 2009, 45(12):692-697.
7. Williams CJ, Jacobs AM: The impact of otitis media on cognitive and
educational outcomes. Med J Aust 2009, 191(9 Suppl):S69-72.
8. Leach AJ, Morris PS, Mathews JD: Compared to placebo, long-term
antibiotics resolve otitis media with effusion (OME) and prevent acute
otitis media with perforation (AOMwiP) in a high-risk population: a
randomized controlled trial. BMC Pediatr 2008, 8:23.
9. Morris PS, Gadil G, McCallum GB, Wilson CA, Smith-Vaughan HC, Torzillo P,
Leach AJ: Single-dose azithromycin versus seven days of amoxycillin in
the treatment of acute otitis media in Aboriginal children (AATAAC): a
double blind, randomised controlled trial. Med J Aust 2010, 192(1):24-29.
10. Jansen AG, Hak E, Veenhoven RH, Damoiseaux RA, Schilder AG, Sanders EA:
Pneumococcal conjugate vaccines for preventing otitis media. Cochrane
Database Syst Rev 2009, , 2: CD001480.
11. Mackenzie GA, Carapetis JR, Leach AJ, Morris PS: Pneumococcal
vaccination and otitis media in Australian Aboriginal infants: comparison
of two birth cohorts before and after introduction of vaccination. BMC
Pediatr 2009, 9:14.
12. Alper CM, Winther B, Mandel EM, Hendley JO, Doyle WJ: Rate of
concurrent otitis media in upper respiratory tract infections with specific
viruses. Archives of otolaryngology–head & neck surgery 2009, 135(1):17-21.
13. Moore HC, Jacoby P, Taylor A, Harnett G, Bowman J, Riley TV, Reuter K,
Smith DW, Lehmann D: The Interaction Between Respiratory Viruses and
Pathogenic Bacteria in the Upper Respiratory Tract of Asymptomatic
Aboriginal and Non-Aboriginal Children. Pediatr Infect Dis J 2010,
29(6):540-5.
14. Jacoby P, Watson K, Bowman J, Taylor A, Riley TV, Smith DW, Lehmann D:
Modelling the co-occurrence of Streptococcus pneumoniae with other
bacterial and viral pathogens in the upper respiratory tract. Vaccine 2007,
25(13):2458-2464.
15. Syrmis MW, Whiley DM, Thomas M, Mackay IM, Williamson J, Siebert DJ,
Nissen MD, Sloots TP: A sensitive, specific, and cost-effective multiplex
reverse transcriptase-PCR assay for the detection of seven common
respiratory viruses in respiratory samples. J Mol Diagn 2004, 6(2):125-131.
16. Avadhanula V, Rodriguez CA, Devincenzo JP, Wang Y, Webby RJ, Ulett GC,
Adderson EE: Respiratory viruses augment the adhesion of bacterial
pathogens to respiratory epithelium in a viral species- and cell type-
dependent manner. J Virol 2006, 80(4):1629-1636.
17. McCullers JA: Insights into the interaction between influenza virus and
pneumococcus. Clin Microbiol Rev 2006, 19(3):571-582.
18. Diavatopoulos DA, Short KR, Price JT, Wilksch JJ, Brown LE, Briles DE,
Strugnell RA, Wijburg OL: Influenza A virus facilitates Streptococcus
pneumoniae transmission and disease. FASEB J 2010, 24(6):1789-1798.
19. Peltola VT, McCullers JA: Respiratory viruses predisposing to bacterial
infections: role of neuraminidase. Pediatr Infect Dis J 2004, 23(1 Suppl):
S87-97.
20. McCullers JA, Bartmess KC: Role of neuraminidase in lethal synergism
between influenza virus and Streptococcus pneumoniae. J Infect Dis
2003, 187(6):1000-1009.
21. El-Ahmer OR, Braun JM, Amyes SG, Weir DM, Beuth J, Blackwell CC:
Comparison of Moraxella catarrhalis isolates from children and adults for
growth on modified New York City medium and potential virulence
factors. J Med Microbiol 2003, 52(Pt 10):853-859.
22. Chung MH, Griffith SR, Park KH, Lim DJ, DeMaria TF: Cytological and
histological changes in the middle ear after inoculation of influenza A
virus. Acta Otolaryngol 1993, 113(1):81-87.
23. Park K, Bakaletz LO, Coticchia JM, Lim DJ: Effect of influenza A virus on
ciliary activity and dye transport function in the chinchilla eustachian
tube. Ann Otol Rhinol Laryngol 1993, 102(7):551-558.
24. Bakaletz LO: Viral potentiation of bacterial superinfection of the
respiratory tract. Trends Microbiol 1995, 3(3):110-114.
25. Vu HT, Yoshida LM, Suzuki M, Nguyen HA, Nguyen CD, Nguyen AT, Oishi K,
Yamamoto T, Watanabe K, Vu TD, et al: Association Between
Nasopharyngeal Load of Streptococcus pneumoniae, Viral Coinfection,
and Radiologically Confirmed Pneumonia in Vietnamese Children. Pediatr
Infect Dis J 2010, 30(1):11-8.
26. Bialasiewicz S, Whiley DM, Lambert SB, Gould A, Nissen MD, Sloots TP:
Development and evaluation of real-time PCR assays for the detection of
the newly identified KI and WU polyomaviruses. J Clin Virol 2007, 40(1):9-14.
27. Tozer SJ, Lambert SB, Whiley DM, Bialasiewicz S, Lyon MJ, Nissen MD,
Sloots TP: Detection of human bocavirus in respiratory, fecal, and blood
samples by real-time PCR. Journal of medical virology 2009, 81(3):488-493.
28. Nadkarni MA, Martin FE, Jacques NA, Hunter N: Determination of bacterial
load by real-time PCR using a broad-range (universal) probe and
primers set. Microbiology (Reading, England) 2002, 148(Pt 1):257-266.
29. McAvin JC, Reilly PA, Roudabush RM, Barnes WJ, Salmen A, Jackson GW,
Beninga KK, Astorga A, McCleskey FK, Huff WB, et al: Sensitive and specific
method for rapid identification of Streptococcus pneumoniae using real-
time fluorescence PCR. J Clin Microbiol 2001, 39(10):3446-3451.
30. Greiner O, Day PJ, Altwegg M, Nadal D: Quantitative detection of
Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR. J
Clin Microbiol 2003, 41(4):1386-1390.
31. Heikkinen T, Ruuskanen O: Temporal development of acute otitis media
during upper respiratory tract infection. Pediatr Infect Dis J 1994,
13(7):659-661.
32. Miyamoto N, Bakaletz LO: Kinetics of the ascension of NTHi from the
nasopharynx to the middle ear coincident with adenovirus-induced
compromise in the chinchilla. Microb Pathog 1997, 23(2):119-126.
33. Rotbart HA: Antiviral therapy for enteroviruses and rhinoviruses. Antivir
Chem Chemother 2000, 11(4):261-271.
34. Chonmaitree T, Revai K, Grady JJ, Clos A, Patel JA, Nair S, Fan J,
Henrickson KJ: Viral upper respiratory tract infection and otitis media
complication in young children. Clin Infect Dis 2008, 46(6):815-823.
35. Lenaerts L, De Clercq E, Naesens L: Clinical features and treatment of
adenovirus infections. Rev Med Virol 2008, 18(6):357-374.
36. Hament JM, Kimpen JL, Fleer A, Wolfs TF: Respiratory viral infection
predisposing for bacterial disease: a concise review. FEMS immunology
and medical microbiology 1999, 26(3-4):189-195.
37. Winther B, Block SL, Reisinger K, Dutkowski R: Impact of oseltamivir
treatment on the incidence and course of acute otitis media in children
with influenza. Int J Pediatr Otorhinolaryngol 2010, 74(6):684-688.
38. Cripps AW, Otczyk DC: Prospects for a vaccine against otitis media. Expert
Rev Vaccines 2006, 5(4):517-534.
39. Heikkinen T, Ruuskanen O, Waris M, Ziegler T, Arola M, Halonen P: Influenza
vaccination in the prevention of acute otitis media in children. Am J Dis
Child 1991, 145(4):445-448.
40. Clements DA, Langdon L, Bland C, Walter E: Influenza A vaccine decreases
the incidence of otitis media in 6- to 30-month-old children in day care.
Arch Pediatr Adolesc Med 1995, 149(10):1113-1117.
41. Marchisio P, Cavagna R, Maspes B, Gironi S, Esposito S, Lambertini L,
Massimini A, Herzog C, Principi N: Efficacy of intranasal virosomal
influenza vaccine in the prevention of recurrent acute otitis media in
children. Clin Infect Dis 2002, 35(2):168-174.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2334/11/161/prepub
doi:10.1186/1471-2334-11-161
Cite this article as: Binks et al.: Viral-bacterial co-infection in Australian
Indigenous children with acute otitis media. BMC Infectious Diseases 2011
11:161.
Binks et al. BMC Infectious Diseases 2011, 11:161
http://www.biomedcentral.com/1471-2334/11/161
Page 8 of 8
